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Introduction
Exercise is considered a safe, feasible, and effective adju-
vant therapy for people with breast cancer.1 Exercise may 
reduce treatment-related side effects, the risk of breast can-
cer recurrence, and mortality and enhance health outcomes 
and quality of life.1,2 For breast cancer survivors who 
develop lymphedema, resistance exercise has been demon-
strated to improve symptom severity, strength, endurance, 
and mobility of the affected limb, without exacerbating 
lymphedema.3-5 However, breast cancer survivors face a 
number of difficulties and barriers to exercise participation. 
These include treatment-related side effects such as fatigue, 
nausea, pain, weight gain, and depression6 as well as the 
presence of uncertainty and fear toward exercise, in that it 
may lead to worsening of lymphedema or its associated 
symptoms.7 Lymphedema risk reduction and management 
guidelines advise patients to avoid physical trauma to the 
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Abstract
Background. Resistance exercise is emerging as a potential adjunct therapy to aid in the management of breast cancer–
related lymphedema (BCRL). However, the mechanisms underlying the relationships between the acute and long-term 
benefits of resistance exercise on BCRL are not well understood. Purpose. To examine the acute inflammatory response to 
upper-body resistance exercise in women with BCRL and to compare these effects between resistance exercises involving 
low, moderate, and high loads. The impact on lymphedema status and associated symptoms was also compared. Methods. 
A total of 21 women, 62 ± 10 years old, with BCRL participated in the study. Participants completed low-load (15-20 
repetition maximum [RM]), moderate-load (10-12 RM), and high-load (6-8 RM) exercise sessions consisting of 3 sets of 6 
upper-body resistance exercises. Sessions were completed in a randomized order separated by a 7- to 10-day wash-out 
period. Venous blood samples were obtained to assess markers of exercise-induced muscle damage and inflammation. 
Lymphedema status was assessed using bioimpedance spectroscopy and arm circumferences, and associated symptoms 
were assessed using Visual Analogue Scales for pain, heaviness, and tightness. Measurements were conducted before and 
24 hours after the exercise sessions. Results. No significant changes in creatine kinase, C-reactive protein, interleukin-6, and 
tumor necrosis factor-α were observed following the 3 resistance exercise sessions. There were no significant changes in 
arm swelling or symptom severity scores across the 3 resistance exercise conditions. Conclusions. The magnitude of acute 
exercise-induced inflammation following upper-body resistance exercise in women with BCRL does not vary between 
resistance exercise loads.
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affected limb to reduce the risk of infection and cellulitis 
occurring as a result of impaired lymphatic function.8 This 
includes avoiding needles, injections, blood draws and 
blood pressure cuffs, and cuts and scratches on the affected 
hand and arm.9 As a result, difficulties exist in undertaking 
invasive studies evaluating resistance exercise in women 
with breast cancer–related lymphedema (BCRL). 
Accordingly, the volume of previous research examining 
the physiological effect of resistance exercise in this cohort 
is limited. In addition, the mechanisms underlying the rela-
tionships between the acute and long-term benefits of resis-
tance exercise and BCRL are not well understood.
Single bouts of resistance exercise elicit muscle tissue 
damage and an acute inflammatory response.10-12 The extent 
of this response is affected by the mode (eccentric and/or 
concentric muscular contractions), volume (total work of 
the session), load (weight lifted), and intensity (extent of 
neuromuscular fatigue) of resistance exercise.13-15 High-
volume and eccentric resistance exercise causes a greater 
magnitude of exercise-induced muscle damage and inflam-
mation.11,16-19 This response is characterized by a tran-
sient increase in creatine kinase (CK) and inflammatory 
biomarkers (eg, interleukin-6 [IL-6], tumor necrosis factor 
α [TNF-α], and C-reactive protein [CRP]) up to 72 hours 
postexercise.11,20-24 Whereas single bouts of resistance exer-
cise cause increases in these biomarkers, chronic adaptation 
to regular exercise has an anti-inflammatory effect associ-
ated with downregulation of various inflammatory bio-
markers.20,25-28 This adaptation is characterized by lower 
resting levels of inflammatory biomarkers. The acute 
inflammatory response to resistance exercise has been 
reported in healthy trained and untrained individuals14 but 
has yet to be examined in women with BCRL who have 
compromised lymphatic system function. There is a percep-
tion among health professionals and patients that if resis-
tance exercise is conducted it should be prescribed at light 
loads. This perception is based on the assumption (yet to be 
empirically evaluated) that lighter loads elicit a lower 
inflammatory response in women with BCRL. However, it 
has been reported that at least in young healthy men, there 
are no differences to the response of CK, IL-6, or TNF-α 24 
hours after upper-body resistance exercise at 4 different 
loads (ranging from 50% to 110% of maximal muscular 
strength; ie, 1 repetition maximum [RM]).29 At present, it is 
unknown if the impaired lymphatic system of women with 
BCRL prompts a different inflammatory response to vary-
ing loads of resistance exercise. The response may differ 
from that in healthy adults because the lymphatic system is 
implicated in cytokine production and removal. It is sug-
gested that in addition to the blood, cytokines may also 
enter the lymph fluid, which can modify plasma cytokine 
levels.30 Furthermore, lymphatic fluid passes through lymph 
nodes, a site where immune cells are removed. As a result, 
cytokine production may be modulated when components 
of damaged muscle pass through lymph nodes.30 However, 
it is unknown whether the excision of lymph nodes and 
lymphatic fluid accumulation in BCRL may alter the 
inflammatory response to exercise.
Women who develop BCRL experience impairment 
within the lymphatic system, resulting in reduced or stag-
nant flow of lymph fluid.31,32 As a result of lymph stasis, 
fibrosis, fat accumulation, and inflammation occur within 
the affected limb.33 This impaired lymph flow results in the 
buildup of protein-rich fluid, which is associated with 
inflammation in the lymphadetamous limb.33-35 Ongoing 
and worsening inflammatory processes of the skin, subcuta-
neous tissue, and lymphatic system also occur.36 As a result 
of the pathological changes in the affected limb, it is plau-
sible that the normal inflammatory response to a bout of 
upper-body resistance exercise is exacerbated or at least 
altered in patients with BCRL. This may have important 
implications in understanding the pathophysiology, upper-
limb rehabilitation, and prescription of optimal resistance 
exercise loads for women with BCRL. Therefore, the aim of 
the present study was to examine the acute inflammatory 
responses to resistance exercise in women with BCRL. 
Markers of exercise-induced muscle damage and inflamma-
tion (CK, CRP, IL-6, and TNF-α) in women with unilateral 
BCRL were evaluated after performing acute bouts of low-, 
moderate-, and high-load upper-body resistance exercises. 
The impact on lymphedema status and associated symp-
toms (pain, heaviness, and tightness) were also assessed.
Methods
Participants
A total of 126 women with BCRL were screened for partici-
pation in this study between August 2011 and February 
2012 (Figure 1). Potential participants were identified 
through referral from oncologists or physiotherapists and 
existing databases of the investigators. A total of 25 women 
were enrolled to participate. To be eligible, participants had 
to have had a histological diagnosis of breast cancer and a 
clinical diagnosis of unilateral BCRL defined as: (1) an 
impedance ratio of at least 3 standard deviations (SDs) 
greater than normative data;37,38 (2) a volume difference 
between affected and unaffected limbs of at least 5%;38,39 
and (3) a difference in circumference between affected and 
unaffected limbs of at least 5%.5,38,39 Women were excluded 
from participation if they had unstable lymphedema, which 
was defined as receiving intensive therapy (ie, decongestive 
therapy or antibiotics for infection) within the previous 3 
months. Any potential participants were also excluded if 
they had a musculoskeletal, cardiovascular, and/or neuro-
logical disorder that could inhibit them or place them at risk 
of harm from exercising, as determined by their general 
physician. This study was approved by the university’s 
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human research ethics committee, and all participants pro-
vided written informed consent.
Experimental Design
A randomized, cross-over design was implemented in which 
participants completed 3 experimental conditions separated 
by a wash-out period of at least 1 week. Prior to any experi-
mental conditions, all participants completed a series of 4 
familiarization sessions implemented twice weekly for a 
fortnight. These sessions involved familiarizing participants 
with the resistance exercises and loads performed during the 
experimental conditions. The experimental conditions 
involved an upper-body resistance exercise session under-
taken using: (1) low load; (2) moderate load; or (3) high 
load. Sessions were completed in a randomized order as 
determined by a random assignment computer program. A 
series of assessments were conducted immediately prior to 
and 24 hours after each of the experimental conditions. 
Instructions were provided to all participants to maintain 
their normal lymphedema management strategies through-
out the duration of the study. Additionally, participants were 
instructed to maintain their standard diet and physical activ-
ity levels throughout the study period.
Resistance Exercise Sessions
Each of the experimental sessions involved a series of 6 
standard resistance exercises targeting all the major muscle 
groups in the upper body. Specifically, the exercises 
Figure 1. Flow of participants throughout trial.
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included the chest press, lat pull-down, bicep curl, triceps 
extension, lateral raise, and wrist curl. Three sets of each 
exercise were performed in each session, whereas the load 
lifted and number of repetitions completed in each set dif-
fered between the 3 experimental conditions. The low-load 
trial involved sets of 15 to 20 RM (ie, load corresponding to 
the maximum weight that could be lifted 15-20 times). The 
moderate-load trial involved sets of 10 to 12 RM. The high-
load trial involved sets of 6 to 8 RM. These RM ranges were 
estimated to represent 55% to 65%, 65% to 75%, and 80% 
to 85% of the 1 RM (ie, maximal strength), respectively.40 
These loading protocols have been shown to be safe for 
women with BCRL3,4 and are consistent with common 
resistance exercise prescriptions used in clinical practice.41 
The participant’s perception of exertion associated with 
each of the experimental conditions was assessed using the 
Rating of Perceived Exertion (RPE) Scale, which quantifies 
the difficulty of the exercise session on a scale from 6 (no 
exertion at all) to 20 (maximal exertion).42 Perceived toler-
ance of each exercise session was assessed using a 7-point 
Likert scale, ranging from 1 (strongly disagree) to 7 
(strongly agree) in response to the statement, “I have found 
the exercise session to be tolerable.” All exercise sessions 
were supervised by an accredited exercise physiologist.
Inflammatory Markers
Venous blood samples were collected from the nonaffected 
arm by a qualified phlebotomist immediately prior to and 
24 hours following the exercise sessions. Because of risk 
reduction guidelines among this cohort (ie, guidelines to 
minimize injections to the hand and arm), we aimed to min-
imize patient burden by allowing 24 hours between blood 
withdrawals. This sampling time point (24 hours) also 
allowed us to determine whether a robust and sustained 
inflammatory response was induced by exercise. Samples 
were assessed for CK, CRP, IL-6, and TNF-α using stan-
dard techniques. CK was assessed by a commercial pathol-
ogy laboratory using the ADVIA Chemistry System 
(Western Diagnostics, Perth, Western Australia). The assay 
sensitivity was <1 U/L, and the precision (coefficient of 
variation) was 1.5%. CRP, IL-6, and TNF-α were assessed 
using multiplex bead-based immunoassays on the Luminex 
platform (Luminex, Austin, TX). Assays were conducted 
using magnetic multiplex kits in accordance with manufac-
turer’s protocol (Merck Millipore, St Charles, MO). The 
sensitivity was 451 ng/mL for CRP, 0.13 pg/mL for IL-6, 
and 0.23 pg/mL for TNF-α. The precision was 8.8% for 
CRP and IL-6 and 6.6% for TNF-α.
Lymphedema Status and Associated Symptoms
The extent of swelling was determined by 2 independent 
techniques: bioimpedance spectroscopy (BIS) and arm 
circumferences. In accordance with the manufacturer’s 
guidelines for the BIS device (ImpediMed IMPTM DF50; 
ImpediMed, San Diego, CA), the impedance of the extracel-
lular fluid in the affected and nonaffected arms was assessed 
using a range of frequencies and compared to produce a 
L-Dex score.37 Regional arm circumferences of the affected 
and nonaffected arms were assessed according to established 
protocols.38,43 The participant was seated with the arm 
abducted at 90°; a constant tension tape was used to measure 
circumferences immediately distal to the metacarpal-pha-
langeal joint and at 5-cm intervals to the base of the axilla. 
Arm circumference swelling was reported as the percentage 
difference in total circumference between the affected and 
nonaffected arms. The severity of lymphedema symptoms 
was assessed using Visual Analogue Scales (VAS) for pain, 
heaviness, and tightness.44 The scales ranged from 0 (no dis-
comfort) to 10 (worst imaginable), and participants rated 
both the affected and nonaffected arms.
Statistical Analyses
Summary descriptive statistics for participants’ characteris-
tics included counts (and percentages) for categorical vari-
ables and means ± SDs or medians, minimum, and 
maximum for continuous variables. Generalized estimating 
equations (GEEs) were used to model continuous primary 
outcomes (CK, CRP, TNF-α, and IL-6) to determine time 
(pre-exercise and 24-hours postexercise) and trial (low-, 
moderate-, and high-load) effects and Time × Trial interac-
tions. GEEs were considered the most appropriate multi-
variate modeling technique. In comparison to conventional 
repeated-measure techniques, GEEs incorporate all avail-
able data (including from participants with missing data at 
various time points). Secondary outcomes (lymphedema 
status and associated symptoms) were analyzed using 
repeated-measures analysis of variance. All tests were 
2-tailed, with an α level of P ≤ .05 as the criterion for statis-
tical significance. No imputation of data was generated. 
Data were analyzed using SPSS Statistics for Windows, 
Version 21 (IBM SPSS, Chicago, IL).
Results
Participant Characteristics
Participants were on average 61.5 years old and had had 
lymphedema for an average of 9 years (Table 1). Most par-
ticipants were either overweight or obese (91%) as deter-
mined by body mass index and had undergone previous 
surgery (96%), with an average of 17 lymph nodes removed. 
Between 60% and 80% of participants had had previous 
radiotherapy and/or chemotherapy or were currently and/or 
previously taking hormone therapy. According to the 
American Physical Therapy Association lymphedema 
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criteria,39 41%, 18%, and 41% of participants had mild, 
moderate, and severe lymphedema, respectively. Most par-
ticipants (86%) self-reported being physically active prior 
to study participation. All participants maintained their 
usual lymphedema self-care management, physical activ-
ity, and diet behaviors for the duration of the study. One 
participant completed only the low-load trial and withdrew 
from the study as a result of a change in work commit-
ments, whereas another participant did not complete the 
moderate-load trial (because of unrelated health concerns). 
Three participants did not complete the 24-hour assessment 
after moderate-load resistance exercise. It was also not pos-
sible to perform the BIS assessments on 1 participant.
Resistance Exercise Sessions
Mean ratings of perceived exertion for the 3 exercise condi-
tions were similar. The participants rated the exercise ses-
sions between “light” and “somewhat hard” (Table 2). 
Participants rated the 3 exercise conditions as equally toler-
able (Table 2). The load lifted across all 6 exercises differed 
significantly between the 3 exercise conditions (low load = 
31.7 ± 18.5 kg; moderate load = 40.7 ± 21.2 kg; high load = 
46.9 ± 26.8 kg; P < .001 [Table 2]). Total volume-load (load 
[kg] × repetitions × sets) was 1300 ± 1091 kg in the low-
load trial, 840 ± 514 kg in the moderate-load trial, and 1011 
± 650 kg in the high-load trial. There were no adverse 
events during participation in the resistance exercise ses-
sions, including no exacerbations of lymphedema or symp-
tom severity.
Inflammatory Markers
There was no significant interaction effect between time 
and trial for CK, CRP, IL-6, and TNF-α (Table 3, 
Supplementary Table [available at http://ict.sagepub.com/
supplemental]). There was a trend for CK to increase (non-
significantly) 24 hours after each of the 3 exercise condi-
tions, with no significant differences between the low-, 
moderate-, and high-load conditions. There were no clear 
trends in terms of the impact of resistance exercise load on 
CRP, IL-6, or TNF-α from pre-exercise to 24 hours postex-
ercise in any of the 3 conditions. Individual responses var-
ied markedly from no change to increases and/or reductions 
in CK, CRP, TNF-α, and IL-6 (Figure 2).
Lymphedema Status and Associated Symptoms
No significant increases were observed in BIS or interlimb 
circumference difference at any time point during the 3 
exercise conditions (Table 4). BIS scores and interlimb cir-
cumference differences generally tended to decrease at 24 
hours after exercise in all 3 conditions. Circumference dif-
ference decreased significantly 24 hours after low-load 
resistance exercise (P = .02). There was no worsening of 
symptom severity of the affected arm at any time through-
out the study. Tightness ratings of the affected arm decreased 
significantly 24 hours after the high-load trial (P = .015).
Discussion
The main findings of this study were the following: (1) no 
significant changes in indicators of muscle damage or 
Table 1. Participant Characteristics (n = 21).
Characteristics
Mean ± SD or 
n (%)
Age (years)   61.5 ± 10.1
Body mass (kg)   82.2 ± 16.2
Body mass index (kg/m²)
 Normal (18.5-24.9) 2 (9.1%)
 Overweight (25-29.9) 8 (36.4%)
 Obese (≥30) 12 (54.5%)
Presence of comorbiditiesa
 0 7 (31.8%)
 1 4 (18.2%)
 2 7 (31.8%)
 3+ 4 (18.2%)
Time since cancer diagnosis (years) 9.4 ± 8.9
Cancer stage
 I 4 (18.2%)
 II 5 (22.7%)
 III 4 (18.2%)
 IV 2 (9.1%)
 Missing 7 (31.8%)
Adjuvant treatment (yes)
 Radiotherapy 17 (77.3%)
 Chemotherapy 16 (72.7%)
 Hormone therapy (currently and/
or previously)
13 (59.1%)
Surgery (yes) 21 (95.5%)
Full axillary clearance (yes) 16 (72.7%)
Number of lymph nodes dissected 16.6 ± 7.7
Years since lymphedema diagnosis  9.4 ± 8.9
Lymphedema treatment in previous 
3 months (yes)
8 (36.4%)
Lymphedema severityb
 Mild 9 (40.9%)
 Moderate 4 (18.2%)
 Severe 9 (40.9%)
Currently physically activec (yes) 19 (86.4%)
Abbreviation: SD, standard deviation.
aComorbidities include hypertension/high blood pressure, high 
cholesterol, cardiovascular disease or heart disease, diabetes, and 
osteoporosis.
bAccording to the American Physical Therapy Association lymphedema 
criteria.15
cPhysically active defined as meeting the Australian national physical 
activity guidelines.53
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inflammation occurred 24 hours after resistance exercise in 
women with BCRL; (2) the acute inflammatory responses 
in women with BCRL were similar across low-, moderate-, 
and high-load resistance exercise conditions; (3) resistance 
exercise did not acutely exacerbate BCRL, regardless of the 
resistance exercise load; and (4) participants reported no 
differences in tolerability or perceived exertion between the 
3 different loading conditions. However, the changes 
observed following all 3 conditions in the present study 
were modest and not clinically relevant (all changes repre-
sented small effects: d < 0.2).
Resistance exercise may elicit muscle damage and associ-
ated inflammation characterized by increases in CK and vari-
ous inflammatory biomarkers.45 Inflammatory cytokines are 
Table 2. Mean Perceived Exertion and Tolerability, as Well as the Loads Lifted, for the Low-, Moderate-, and High-Load Conditions.
Low Load,a 
Mean ± SD
Moderate Load,a 
Mean ± SD
High Load,a 
Mean ± SD
Perceived exertion (RPE scale)b 12.7 ± 1.9 12.6 ± 0.9 13.1 ± 1.8
Tolerability (7-point Likert scale)c 6.4 ± 0.8 5.9 ± 1.5 6.4 ± 0.7
Resistance exercise loads
 Chest press (kg) 10.8 ± 6.4 12.8 ± 7.4 14.7 ± 8.3
 Lat-pulldown (kg) 13.2 ± 8.0 16.2 ± 9.5 19.0 ± 10.9
 Biceps curl (kg) 2.2 ± 0.4 2.8 ± 0.6 3.5 ± 0.7
 Lateral raise (kg) 1.7 ± 0.4 2.1 ± 0.5 2.6 ± 0.6
 Triceps extension (kg) 3.4 ± 3.6 5.1 ± 5.5 6.5 ± 6.7
 Wrist curl (kg) 1.9 ± 0.5 4.3 ± 3.5 3.2 ± 0.9
Abbreviation: RPE, Rating of Perceived Exertion.
aThe load lifted differed significantly between the 3 exercise conditions.
bPerceived exertion assessed using a 6 (no exertion at all) to 20 (maximal exertion) scale.
cTolerability assessed using a 1 (strongly disagree) to 7 (strongly agree) scale in response to the statement, “I have found the exercise session to be 
tolerable.”
Table 3. Lymphedema Status and Associated Symptom Severity Before and 24 Hours After Low-, Moderate-, and High-Load 
Conditions (Mean ± SD).
Extent of Swelling Symptom Severity
 BIS (L-Dex)
Circumference 
Differencea (%) Pain (mm) Heaviness (mm)
Tightness 
(mm)
Low-load resistance exercise
 Pre-exercise (n = 20) 15.19 ± 18.97 6.73 ± 5.79 0.35 ± 0.75 0.67 ± 1.18 0.75 ± 1.19
 24 Hours postexercise (n = 20) 12.87 ± 16.55  5.96 ± 6.11b 0.40 ± 0.88 0.68 ± 1.13 0.87 ± 1.31
 Mean change from pre-exercise 
to 24 hours postexercise 
(95% CI)
−2.51  
(−7.22, 2.19)
−0.77  
(−1.41, −0.13)
+0.04  
(−0.07, 0.17)
+0.01  
(−0.33, 0.33)
+0.12  
(−0.17, 0.42)
Moderate-load resistance exercise
 Pre-exercise (n = 16) 16.38 ± 23.00 8.13 ± 6.76 0.11 ± 0.14 0.78 ± 1.67 0.67 ± 1.23
 24 Hours postexercise (n = 16) 13.86 ± 19.25 6.93 ± 6.06 0.50 ± 1.58 1.22 ± 1.93 1.28 ± 2.35
 Mean change from pre-exercise 
to 24 hours postexercise 
(95% CI)
−2.51  
(−7.22, 2.19)
−1.20  
(–3.32, 0.92)
+0.38  
(−0.55, 1.32)
+0.43  
(−0.38, 1.25)
+0.60  
(−0.34, 1.55)
High-load resistance exercise
 Pre-exercise (n = 21) 16.71 ± 18.89 5.59 ± 6.24 0.40 ± 0.87 0.98 ± 1.60 1.18 ± 1.86
 24 Hours postexercise (n = 21) 14.16 ± 16.85 5.49 ± 5.26 0.26 ± 0.52 0.73 ± 1.49  0.65 ± 1.44c
 Mean change from pre-exercise 
to 24 hours postexercise 
(95% CI)
−2.54  
(−5.23, 0.14)
−0.10  
(−1.48, 1.28)
−0.13  
(−0.33, 0.61)
−0.25  
(−0.55, 0.03)
−0.52  
(−0.93, −0.11)
Abbreviations: SD, standard deviation; BIS, bioimpedance spectroscopy; CI, confidence interval.
aInterlimb circumference difference.
bSignificantly different from pre-exercise (P = .02).
cSignificantly different from pre-exercise (P = .015).
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Figure 2. Individual response in markers of muscle damage and inflammation presented as the mean change from pre-exercise to 24 
hours postexercise for low-, moderate-, and high-load conditions.a
a*Denotes extreme outliers (≥3 × interquartile range); ○ denotes mild outliers (≥1.5 × interquartile range).
Table 4. Inflammatory Marker Response, Including CK, CRP, TNF-α, and IL-6, to the Resistance Exercise Conditions From Pre-
exercise to 24 Hours Postexercise.
Low Load, Mean ± SD Moderate Load, Mean ± SD High Load, Mean ± SD
CK (U/L)
 Pre-exercise 85.80 ± 45.95 98.07 ± 76.15 83.52 ± 54.06
 Change from pre-exercise to 24 
hours postexercise (95% CI)
0.70 (−9.29, 10.69) 1.07 (−5.73, 7.87) 5.89 (−3.29, 15.08)
CRP (ng/mL)
 Pre-exercise 7.56 ± 5.36 5.97 ± 5.63 6.69 ± 5.79
 Change from pre-exercise to 24 
hours postexercise (95% CI)
−0.30 (−1.39, 0.78) 0.66 (−0.57, 1.90) −0.40 (−1.65, 0.84)
TNF-α (pg/mL)
 Pre-exercise 10.13 ± 6.81 8.65 ± 8.37 10.06 ± 6.97
 Change from pre-exercise to 24 
hours postexercise (95% CI)
0.67 (−0.50, 1.84) 0.04 (−2.73, 2.83) −0.36 (−1.66, 0.92)
IL-6 (ng/mL)
 Pre-exercise 2.23 ± 4.29 2.58 ± 5.59 2.65 ± 5.42
 Change from pre-exercise to 24 
hours postexercise (95% CI)
0.58 (−0.48, 1.65) 0.64 (−0.27, 1.56) −0.05 (−0.51, 0.39)
Abbreviations: CK, creatine kinase; CRP, C-reactive protein; TNF, tumor necrosis factor; IL-6, interleukin-6; SD, standard deviation; CI, confidence 
interval.
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intracellular signaling molecules involved in initiating the 
inflammatory responses to exercise-induced muscle damage 
and adaptation.14,30 Clinicians have been hesitant to recom-
mend resistance training (and in particular moderate to high 
loads) for women with BCRL. There is a perception that 
lighter-load resistance training will produce less muscle dam-
age and inflammation compared with higher-load resistance 
training (eg, large increases in CK have been observed after 
strenuous exercise46), and there are concerns that the inflam-
mation would exacerbate BCRL as a result of impaired lymph 
flow. Furthermore, there are concerns that resistance exercise 
with heavy loads may exacerbate lymphedema symptoms, 
and women with BCRL are typically apprehensive about lift-
ing weights, especially at heavier loads.7 However, participa-
tion in an acute high-load resistance exercise session has 
recently been demonstrated to not acutely increase swelling or 
symptom severity of the affected limb in women with BCRL.3 
Importantly, the current study extends these previous observa-
tions to indicate that there may be no difference in the inflam-
matory response 24 hours following participation in acute 
bouts of resistance exercise involving low, moderate, or high 
loads. Because inflammatory markers returned to normal 
within 24 hours, there is little evidence that any clinically 
important inflammation occurred. However, it is important to 
note that these are preliminary observations based on a small 
sample of patients who were relatively active. Higher-load 
resistance exercise is known to stimulate greater morphologi-
cal and neural adaptations compared with lower loads.41,47,49 
As such, these preliminary findings suggest that women with 
BCRL can safely participate in moderate- to high-load resis-
tance exercise.
Resistance training–induced muscle damage and subse-
quent inflammatory responses are mediated by a range of 
individual and training program variables.14,15 In the current 
study, increasing the load of resistance exercise did not elicit 
a significantly greater inflammatory response. Similarly, pre-
vious findings suggest that the load of upper-body resistance 
exercise may not affect the magnitude of change in blood 
markers of muscle damage and inflammation. Uchida et al29 
compared 4 different loads of upper-body resistance exercise 
(ranging from 50% to 110% of 1 RM) on various inflamma-
tory biomarkers, including CK, IL-6, and TNF-α in physi-
cally trained men. Regardless of the loading protocol, no 
changes in IL-6 or TNF-α were observed 24 hours after exer-
cise. Uchida et al29 reported significant increases in CK 24 
hours after each exercise trial; however, no difference was 
observed between the different loading protocols in the mag-
nitude of CK change.29 Although there were clear differences 
in the participants sampled, exercise protocols, blood sam-
pling, and measurement techniques between the previous and 
current studies, the findings were consistent. These initial 
findings suggest that BCRL and its associated pathology do 
not alter acute inflammatory response in the 24 hours follow-
ing low-, moderate-, and high-load resistance exercise.
Although more than half of the participants had chronic 
lymphedema (present for on average 9 years), our findings 
suggest that symptom severity may still acutely improve 
with appropriately prescribed resistance exercise. Consistent 
with previous findings,50 a significant reduction in tightness 
of the affected arm was observed 24 hours after a high-load 
resistance exercise session. The possible mechanisms of 
such benefit are unknown, but it could be speculated that 
more effective hydrostatic pressure drove lymph return with 
more forceful muscle actions. In addition, more forceful 
muscle actions may result in favorable hormone and cyto-
kine production, affecting the tissue locally and systemi-
cally. The observation that high-load resistance exercise did 
not induce significantly greater exercise-induced muscle 
damage or inflammation in the present study is supported by 
the subjective improvements in symptom severity of the 
affected limb 24 hours after exercise. It is also important to 
consider that although many of the participants in the study 
were not accustomed to performing regular resistance exer-
cise, participants were generally physically active and had 
undergone a 2-week familiarization protocol. Regular exer-
cise may cause a cumulative anti-inflammatory effect in 
response to repeated bouts of exercise.25,51 Participants were 
likely accustomed to physical activity (albeit not resistance 
exercise in particular); therefore, these findings may not rep-
resent the acute inflammatory response of sedentary or less 
physically active women with BCRL. However, previous 
research in healthy individuals indicates that even a single 
bout of eccentric exercise results in considerable protection 
from muscle damage in subsequent training sessions.30
This is the first study to our knowledge that has com-
pared whether resistance exercise load influences the exer-
cise-induced inflammatory response and the potential 
implications this may have for women with BCRL. We 
examined various markers of exercise-induced muscle 
damage and inflammation in response to varying exercise 
loads. Importantly, all levels of loading (low, moderate, 
and high) were equally tolerable in this sample of women 
with BCRL. Nevertheless, our study was subject to several 
limitations that are worthy of comment. First, our study 
was limited by a relatively small sample size, which may 
limit our ability to detect statistically significant differ-
ences. Second, blood samples were only assessed 24 hours 
postexercise. As a result, we cannot discount that the lack 
of significant increase or difference among the 3 exercise 
bouts may be a result of the clearance of cytokines prior to 
blood withdrawal. Although more frequent sampling would 
have been preferable to demonstrate changes in cytokines 
following resistance exercise (eg, Izquierdo et al19), 24 
hours between blood samples was selected to alleviate 
patient concerns and burden among patients with BCRL. 
Additionally, systemic biomarkers were assessed, and it is 
acknowledged that local responses within skeletal muscle 
may differ.
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Findings from the present study add to the existing body 
of knowledge by establishing that acute bouts of moderate- 
and high-load resistance exercise may not induce a greater 
level of muscle damage or inflammation compared with 
low-load resistance exercise in breast cancer survivors who 
have established lymphedema. This extends previous 
research demonstrating that high-load resistance exercise 
does not exacerbate lymphedema or associated symptoms of 
the affected limb.3,4 Data from this present study may inform 
future exercise intervention studies, and given the greater 
time efficiency and strength adaptation resulting from mod-
erate- to high-load resistance training,41 the efficacy of low-
load resistance exercise appears limited.41 It is well 
established that a strong dose-response relationship exists 
with resistance exercise load.41 Greater improvements in 
muscle strength and hypertrophy, physical function, and 
health-related quality of life are experienced with higher 
load resistance exercise compared with low loads.47,48,52 
Participants reported the same tolerability and RPE regard-
less of load, further supporting the potential appropriateness 
of moderate to high loads for this population. Because regu-
lar exercise has been shown to reduce resting levels of 
inflammatory cytokines in breast cancer survivors without 
lymphedema,51 future studies should aim to examine changes 
in chronic low-grade inflammation with longer-term (eg, 
≥12 weeks) exercise in women with BCRL.
Conclusions
As research continues to emerge demonstrating the safety 
and efficacy of resistance exercise in women with BCRL, 
there remains a limited amount of research investigating 
the physiological responses underlying these benefits. 
Findings from the current exploratory study demonstrate 
that the magnitude of exercise-induced muscle damage 
and inflammation following upper-body resistance exer-
cise in women with BCRL may not be dependent on the 
load of resistance exercise and that low-, moderate-, and 
high-load upper-body resistance exercise may not result in 
a greater 24-hour inflammatory response in individuals 
with impaired lymph flow in the upper limb. Lymphedema 
status and symptom severity as well as perceived tolera-
bility and exertion of resistance exercise were also not 
affected by the load lifted. Given the extensive evidence 
that moderate to high loads in resistance training produce 
greater strength and morphological adaptations as well as 
physical function and health-related quality of life com-
pared with low loads,47,48,52 this study lends further sup-
port for the prescription of moderate- to high-load exercise 
for women with BCRL.
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